<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00313703</url>
  </required_header>
  <id_info>
    <org_study_id>04-03-077E</org_study_id>
    <nct_id>NCT00313703</nct_id>
  </id_info>
  <brief_title>Prospective ED Headache Cohort Study</brief_title>
  <official_title>Predicting Poor Pain and Functional Outcomes After Discharge From the Emergency Department With a Primary Headache</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Montefiore Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institute of Neurological Disorders and Stroke (NINDS)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>Montefiore Medical Center</source>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine how often headaches recur and to learn how to
      predict continued suffering from headache after emergency department discharge.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The majority of the 5 million people who arrive at Emergency Departments (ED) with a headache
      every year are suffering from an acute exacerbation of a chronic, recurrent headache
      disorder. The role of the ED in treating these patients has been ill-defined. Often emergency
      physicians will treat the acute exacerbation and will not attend to the natural history of
      the disease. However, about two thirds of primary headache patients will suffer a recurrent
      headache in the 24 hours after discharge from the ED. And, many patients will continue to
      suffer recurrent headaches for months after their ED discharge.

      The purpose of this study is to learn how often headaches recur and to try to find a way to
      predict who will have a recurrent headache after ED discharge.

      After standard ED treatment for headache, participants in the study will be asked to answer
      questions about prior headaches and medical history, and some census-like questions about
      race/ethnicity, salary, and education via a 20-minute interview with a research associate.
      The researchers will follow-up with 10-minute telephone calls to each participant's home in
      24 hours and in 3 months with additional questions. Total length of time for study
      participation is approximately 40 minutes.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">March 2004</start_date>
  <completion_date type="Actual">November 2005</completion_date>
  <primary_completion_date type="Actual">August 2005</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Number of Participants Who Report Moderate or Severe Pain Within 24 Hours of Emergency Department(ED) Discharge</measure>
    <time_frame>24 hours after Emergency Department (ED) discharge</time_frame>
    <description>Moderate/ Severe pain after discharge from the Emergency Department (ED). Moderate and severe are study subject's description of pain</description>
  </primary_outcome>
  <other_outcome>
    <measure>Number of Participants Who Reported Headache Disability Scores (MIDAS) More Than Minimal</measure>
    <time_frame>3 months</time_frame>
    <description>Headache disability scores. On the MIDAS scale, a score &gt; five signifies more than minimal headache related disability. MIDAS stands for MIgraine Disability Assessment Scale. More information on it can be found at http://www.migraines.org/disability/pdfs/midas.pdf. Scores of 0 are desirable. Scores greater than 20 signify a severe, functionally disabling migraine disorder.</description>
  </other_outcome>
  <enrollment type="Actual">477</enrollment>
  <condition>Headache</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Convenience sample of ED patients
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Emergency Department patients who present primarily for headache.

          -  Need to consent to and be available for follow-up
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Benjamin Friedman, MD, MS</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Emergency Medicine, Montefiore Medical Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Montefiore Medical Center, 111 East 210th Street</name>
      <address>
        <city>Bronx</city>
        <state>New York</state>
        <zip>10467</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 10, 2006</study_first_submitted>
  <study_first_submitted_qc>April 10, 2006</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 12, 2006</study_first_posted>
  <results_first_submitted>October 6, 2010</results_first_submitted>
  <results_first_submitted_qc>April 15, 2011</results_first_submitted_qc>
  <results_first_posted type="Estimate">May 9, 2011</results_first_posted>
  <last_update_submitted>April 16, 2018</last_update_submitted>
  <last_update_submitted_qc>April 16, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 15, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Montefiore Medical Center</investigator_affiliation>
    <investigator_full_name>Benjamin W. Friedman, MD</investigator_full_name>
    <investigator_title>Prof. Emergency Medicine</investigator_title>
  </responsible_party>
  <keyword>headache</keyword>
  <keyword>emergency department</keyword>
  <keyword>migraine</keyword>
  <keyword>recurrent headache</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Headache</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>We enrolled adult patients who presented to one urban emergency department (ED) with a chief complaint of headache.Patients were assigned a headache diagnosis based on criteria established by the International Headache Society (These are available at http://217.174.249.183/upload/CT_Clas/ICHD-IIR1final.pdf)</recruitment_details>
      <pre_assignment_details>477 patients underwent a detailed interview in the ED. 309 of these patients were determined to have a primary headache disorder (a benign recurrent headache disease) and were entered into the post-ED follow-up portion of this cohort study.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Migraine</title>
          <description>met International Headache Society migraine criteria</description>
        </group>
        <group group_id="P2">
          <title>Tension-type Headache</title>
          <description>met International Headache Society tension-type headache criteria</description>
        </group>
        <group group_id="P3">
          <title>Unclassifiable</title>
          <description>Had recurrent headache disorder but did not meet any International Headache Society criteria</description>
        </group>
        <group group_id="P4">
          <title>Other</title>
          <description>Met other International Headache Society criteria</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="186"/>
                <participants group_id="P2" count="34"/>
                <participants group_id="P3" count="77"/>
                <participants group_id="P4" count="12"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="175">Some subjects lost to follow-up</participants>
                <participants group_id="P2" count="32">Some subjects lost-to follow-up</participants>
                <participants group_id="P3" count="72">Some subjects lost-to-follow-up</participants>
                <participants group_id="P4" count="0">Outcomes not reported due to heterogeneity of this group</participants>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="11"/>
                <participants group_id="P2" count="2"/>
                <participants group_id="P3" count="5"/>
                <participants group_id="P4" count="12"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="11"/>
                <participants group_id="P2" count="2"/>
                <participants group_id="P3" count="5"/>
                <participants group_id="P4" count="12"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Migraine</title>
          <description>met International Headache Society migraine criteria</description>
        </group>
        <group group_id="B2">
          <title>Tension-type Headache</title>
          <description>met International Headache Society tension-type headache criteria</description>
        </group>
        <group group_id="B3">
          <title>Unclassifiable</title>
          <description>Had recurrent headache disorder but did not meet any International Headache Society criteria</description>
        </group>
        <group group_id="B4">
          <title>Other</title>
          <description>Met other International Headache Society criteria</description>
        </group>
        <group group_id="B5">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="186"/>
            <count group_id="B2" value="34"/>
            <count group_id="B3" value="77"/>
            <count group_id="B4" value="12"/>
            <count group_id="B5" value="309"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="38" spread="12"/>
                    <measurement group_id="B2" value="40" spread="12"/>
                    <measurement group_id="B3" value="42" spread="12"/>
                    <measurement group_id="B4" value="40" spread="11"/>
                    <measurement group_id="B5" value="39" spread="12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="169"/>
                    <measurement group_id="B2" value="25"/>
                    <measurement group_id="B3" value="54"/>
                    <measurement group_id="B4" value="8"/>
                    <measurement group_id="B5" value="256"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="17"/>
                    <measurement group_id="B2" value="9"/>
                    <measurement group_id="B3" value="23"/>
                    <measurement group_id="B4" value="4"/>
                    <measurement group_id="B5" value="53"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Number of Participants Who Report Moderate or Severe Pain Within 24 Hours of Emergency Department(ED) Discharge</title>
        <description>Moderate/ Severe pain after discharge from the Emergency Department (ED). Moderate and severe are study subject's description of pain</description>
        <time_frame>24 hours after Emergency Department (ED) discharge</time_frame>
        <population>A small number of patients in each group were lost-to-follow-up and could not be included in this analysis.</population>
        <group_list>
          <group group_id="O1">
            <title>Migraine</title>
            <description>met International Headache Society migraine criteria</description>
          </group>
          <group group_id="O2">
            <title>Tension-type Headache</title>
            <description>met International Headache Society tension-type headache criteria</description>
          </group>
          <group group_id="O3">
            <title>Unclassifiable</title>
            <description>Had recurrent headache disorder but did not meet any International Headache Society criteria</description>
          </group>
          <group group_id="O4">
            <title>Other</title>
            <description>Met other International Headache Society criteria</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants Who Report Moderate or Severe Pain Within 24 Hours of Emergency Department(ED) Discharge</title>
          <description>Moderate/ Severe pain after discharge from the Emergency Department (ED). Moderate and severe are study subject's description of pain</description>
          <population>A small number of patients in each group were lost-to-follow-up and could not be included in this analysis.</population>
          <units>Participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="172"/>
                <count group_id="O2" value="32"/>
                <count group_id="O3" value="75"/>
                <count group_id="O4" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="53"/>
                    <measurement group_id="O2" value="6"/>
                    <measurement group_id="O3" value="20"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Number of Participants Who Reported Headache Disability Scores (MIDAS) More Than Minimal</title>
        <description>Headache disability scores. On the MIDAS scale, a score &gt; five signifies more than minimal headache related disability. MIDAS stands for MIgraine Disability Assessment Scale. More information on it can be found at http://www.migraines.org/disability/pdfs/midas.pdf. Scores of 0 are desirable. Scores greater than 20 signify a severe, functionally disabling migraine disorder.</description>
        <time_frame>3 months</time_frame>
        <population>A small number of patients in each group were lost-to-follow-up and could not be included in this analysis.</population>
        <group_list>
          <group group_id="O1">
            <title>Migraine</title>
            <description>met International Headache Society migraine criteria</description>
          </group>
          <group group_id="O2">
            <title>Tension-type Headache</title>
            <description>met International Headache Society tension-type headache criteria</description>
          </group>
          <group group_id="O3">
            <title>Unclassifiable</title>
            <description>Had recurrent headache disorder but did not meet any International Headache Society criteria</description>
          </group>
          <group group_id="O4">
            <title>Other</title>
            <description>Met other International Headache Society criteria</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants Who Reported Headache Disability Scores (MIDAS) More Than Minimal</title>
          <description>Headache disability scores. On the MIDAS scale, a score &gt; five signifies more than minimal headache related disability. MIDAS stands for MIgraine Disability Assessment Scale. More information on it can be found at http://www.migraines.org/disability/pdfs/midas.pdf. Scores of 0 are desirable. Scores greater than 20 signify a severe, functionally disabling migraine disorder.</description>
          <population>A small number of patients in each group were lost-to-follow-up and could not be included in this analysis.</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="175"/>
                <count group_id="O2" value="32"/>
                <count group_id="O3" value="72"/>
                <count group_id="O4" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="65"/>
                    <measurement group_id="O2" value="12"/>
                    <measurement group_id="O3" value="19"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <desc>No adverse event information was gathered.</desc>
      <group_list>
        <group group_id="E1">
          <title>Migraine</title>
          <description>met International Headache Society migraine criteria</description>
        </group>
        <group group_id="E2">
          <title>Tension-type Headache</title>
          <description>met International Headache Society tension-type headache criteria</description>
        </group>
        <group group_id="E3">
          <title>Unclassifiable</title>
          <description>Had recurrent headache disorder but did not meet any International Headache Society criteria</description>
        </group>
        <group group_id="E4">
          <title>Other</title>
          <description>Met other International Headache Society criteria</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="0"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="0"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Benjamin Friedman</name_or_title>
      <organization>Montefiore Medical Center</organization>
      <phone>718-920-6626</phone>
      <email>befriedm@montefiore.org</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

